BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26574608)

  • 1. Germline RBBP6 mutations in familial myeloproliferative neoplasms.
    Harutyunyan AS; Giambruno R; Krendl C; Stukalov A; Klampfl T; Berg T; Chen D; Milosevic Feenstra JD; Jäger R; Gisslinger B; Gisslinger H; Rumi E; Passamonti F; Pietra D; Müller AC; Parapatics K; Breitwieser FP; Herrmann R; Colinge J; Bennett KL; Superti-Furga G; Cazzola M; Hammond E; Kralovics R
    Blood; 2016 Jan; 127(3):362-5. PubMed ID: 26574608
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel germline JAK2 mutation in familial myeloproliferative neoplasms.
    Rumi E; Harutyunyan AS; Casetti I; Pietra D; Nivarthi H; Moriggl R; Cleary C; Bagienski K; Astori C; Bellini M; Berg T; Passamonti F; Kralovics R; Cazzola M
    Am J Hematol; 2014 Jan; 89(1):117-8. PubMed ID: 24142793
    [No Abstract]   [Full Text] [Related]  

  • 3. Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms.
    Loscocco GG; Mannarelli C; Pacilli A; Fanelli T; Rotunno G; Gesullo F; Corbizi-Fattori G; Vannucchi AM; Guglielmelli P
    Am J Hematol; 2016 Sep; 91(9):E356. PubMed ID: 27237057
    [No Abstract]   [Full Text] [Related]  

  • 4. A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.
    Marquez R; Hantel A; Lorenz R; Neistadt B; Wong J; Churpek JE; Mardini NA; Shaukat I; Gurbuxani S; Miller JL; Godley LA
    Leuk Lymphoma; 2014 Dec; 55(12):2945-6. PubMed ID: 24628296
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
    Rumi E; Cazzola M
    Br J Haematol; 2017 Sep; 178(5):689-698. PubMed ID: 28444727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel germline
    Rajpal S; Jain A; Jamwal M; Jain N; Sachdeva MUS; Malhotra P; Varma N; Das R
    Leuk Lymphoma; 2019 Oct; 60(10):2568-2571. PubMed ID: 30990344
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms.
    Lundberg P; Nienhold R; Ambrosetti A; Cervantes F; Pérez-Encinas MM; Skoda RC
    Blood; 2014 Apr; 123(17):2744-5. PubMed ID: 24764562
    [No Abstract]   [Full Text] [Related]  

  • 8. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
    Ghimenti C; Sensi E; Presciuttini S; Brunetti IM; Conte P; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2002 Mar; 33(3):235-42. PubMed ID: 11807980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins.
    Kunapuli P; Somerville R; Still IH; Cowell JK
    Oncogene; 2003 May; 22(22):3417-23. PubMed ID: 12776193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes.
    Maccaferri M; Pierini V; Di Giacomo D; Zucchini P; Forghieri F; Bonacorsi G; Paolini A; Quadrelli C; Giacobbi F; Fontana F; Cappelli G; Potenza L; Marasca R; Luppi M; Mecucci C
    Leuk Lymphoma; 2017 Feb; 58(2):489-493. PubMed ID: 27337990
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloid Neoplasms with Germline Predisposition.
    Geyer JT
    Pathobiology; 2019; 86(1):53-61. PubMed ID: 30048985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
    Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
    Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the
    Palmer D; Nacheva E
    Leuk Lymphoma; 2021 May; 62(5):1255-1258. PubMed ID: 33349109
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia.
    Vairo FPE; Ferrer A; Cathcart-Rake E; King RL; Howard MT; Viswanatha DS; Klee EW; Mangaonkar AA; Patnaik MM
    Leuk Lymphoma; 2019 May; 60(5):1337-1339. PubMed ID: 30407884
    [No Abstract]   [Full Text] [Related]  

  • 16. Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.
    Bellanné-Chantelot C; Rabadan Moraes G; Schmaltz-Panneau B; Marty C; Vainchenker W; Plo I
    Blood Rev; 2020 Jul; 42():100710. PubMed ID: 32532454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of BARD1 in familial breast cancer patients in Japan.
    Ishitobi M; Miyoshi Y; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
    Cancer Lett; 2003 Oct; 200(1):1-7. PubMed ID: 14550946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
    Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
    Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.
    Xiao C; Wang Y; Zheng M; Chen J; Song G; Zhou Z; Zhou C; Sun X; Zhong L; Ding E; Zhang Y; Yang L; Wu G; Xu S; Zhang H; Wang X
    Cancer Sci; 2018 Apr; 109(4):1075-1087. PubMed ID: 29369481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.